No New Trial for the 3rd Xarelto Bellwether Plaintiff
No New Trial for the 3rd Xarelto Bellwether Plaintiff
Introduction
The plaintiff of the 3rd Xarelto bellwether trial, which went in favor of the Xarelto defendants J&J's Janssen Pharmaceuticals and Bayer in August 2017, faced a defeat again when a Louisiana federal judge turned down the request for a new trial.
The plaintiff had planned for a retrial based on the recent scientific study that she hoped could change the jury's mind. Judge Eldon E. Fallon denied her request stating that the newly discovered evidence was actually cumulative of the previously known and admitted evidence.
Xarelto lawsuits are consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana; nearly 22,000 cases are a part of this MDL while more than 1,500 cases are pending in Philadelphia's Complex Litigation Center.
Comments
Latest News
New Front Emerges in Fight Against Synthetic Opioids
Categories: Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…
Exactech to Pay $8M to Settle Defective Knee Implant Suit
Categories: Attune Knee System
Medical device maker Exactech has agreed to an $8 million settlement to resolve allegations that it hid defects in a widely used line of artificial knee implants.
The implants have been linked to thousands of patient injuries and sparked…
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Categories: Talcum
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…